{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T15:33:34Z","timestamp":1794843214556,"version":"4.9.1"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Jiangsu Province","award":["BK20211347"],"award-info":[{"award-number":["BK20211347"]}]},{"name":"the Natural Science Foundation of the Jiangsu Higher Education Institutions","award":["21KJA310004"],"award-info":[{"award-number":["21KJA310004"]}]},{"name":"Xuzhou Technology Bureau Foundation","award":["KC21065"],"award-info":[{"award-number":["KC21065"]}]},{"name":"a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions","award":["PAPD"],"award-info":[{"award-number":["PAPD"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>During chronic hepatitis B virus (HBV) infection, hepatic fibrosis is a serious pathological condition caused by virus-induced liver damage. The activation of hepatic stellate cells (HSCs) is a central event in the occurrence and progression of liver fibrosis. Although accumulating evidence has shown that HBV directly stimulates HSC activation, whether the virus infects and replicates in HSCs remains controversial. Inflammation is one of the obvious characteristics of chronic HBV infection, and it has been demonstrated that persistent inflammation has a predominant role in triggering and maintaining liver fibrosis. In particular, the regulation of HSC activation by HBV-related hepatocytes via various inflammatory modulators, including TGF-\u03b2 and CTGF, in a paracrine manner has been reported. In addition to these inflammation-related molecules, several inflammatory cells are essential for the progression of HBV-associated liver fibrosis. Monocytes, macrophages, Th17 cells, NK cells, as well as NKT cells, participate in the modulation of HBV-related liver fibrosis by interacting with HSCs. This review summarizes current findings on the effects of HBV and the relevant molecular mechanisms involved in HSC activation. Because HSC activation is essential for liver fibrosis, targeting HSCs is an attractive therapeutic strategy to prevent and reverse hepatic fibrosis induced by HBV infection.<\/jats:p>","DOI":"10.1186\/s12964-023-01091-7","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T05:03:23Z","timestamp":1681189403000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Insights into the impact of hepatitis B virus on hepatic stellate cell activation"],"prefix":"10.1186","volume":"21","author":[{"given":"Hongjuan","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiucheng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuiyang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanyun","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renxian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,11]]},"reference":[{"issue":"1","key":"1091_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/hep.32314","volume":"76","author":"S Fung","year":"2022","unstructured":"Fung S, Choi HSJ, Gehring A, Janssen HLA. Getting to HBV cure: the promising paths forward. Hepatology. 2022;76(1):233\u201350.","journal-title":"Hepatology"},{"issue":"3","key":"1091_CR2","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jhep.2021.05.013","volume":"75","author":"MG Martinez","year":"2021","unstructured":"Martinez MG, Boyd A, Combe E, Testoni B, Zoulim F. Covalently closed circular DNA: the ultimate therapeutic target for curing Hepatitis B virus infections. J Hepatol. 2021;75(3):706\u201317.","journal-title":"J Hepatol"},{"key":"1091_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1053\/j.gastro.2018.07.057","volume":"156","author":"Y Xia","year":"2019","unstructured":"Xia Y, Liang TJ. Development of direct-acting antiviral and host-targeting agents for treatment of hepatitis B virus infection. Gastroenterology. 2019;156:311\u201324.","journal-title":"Gastroenterology"},{"key":"1091_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.751516","volume":"8","author":"F Kong","year":"2021","unstructured":"Kong F, Li Q, Zhang F, Li X, You H, Pan X, et al. Sirtuins as potential therapeutic targets for hepatitis B virus infection. Front Med (Lausanne). 2021;8: 751516.","journal-title":"Front Med (Lausanne)"},{"key":"1091_CR5","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1080\/22221751.2021.2006580","volume":"10","author":"A Kostyusheva","year":"2021","unstructured":"Kostyusheva A, Brezgin S, Glebe D, Kostyushev D, Chulanov V. Host-cell interactions in HBV infection and pathogenesis: the emerging role of m6A modification. Emerg Microbes Infect. 2021;10:2264\u201375.","journal-title":"Emerg Microbes Infect"},{"key":"1091_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18:151\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1091_CR7","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s12072-016-9720-y","volume":"10","author":"A Tawada","year":"2016","unstructured":"Tawada A, Kanda T, Imazeki F, Yokosuka O. Prevention of hepatitis B virus-associated liver diseases by antiviral therapy. Hepatol Int. 2016;10:574\u201393.","journal-title":"Hepatol Int"},{"key":"1091_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hep.32285","volume":"75","author":"SL Friedman","year":"2022","unstructured":"Friedman SL, Pinzani M. Hepatic fibrosis 2022: unmet needs and a blueprint for the future. Hepatology. 2022;75:473\u201388.","journal-title":"Hepatology"},{"key":"1091_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14:397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1091_CR10","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1113\/JP281061","volume":"600","author":"DR Kamm","year":"2022","unstructured":"Kamm DR, McCommis KS. Hepatic stellate cells in physiology and pathology. J Physiol. 2022;600:1825\u201337.","journal-title":"J Physiol"},{"key":"1091_CR11","first-page":"1455","volume":"122","author":"X Liu","year":"2009","unstructured":"Liu X, Zhu ST, You H, Cong M, Liu TH, Wang BE, et al. Hepatitis B virus infects hepatic stellate cells and affects their proliferation and expression of collagen type I. Chin Med J (Engl). 2009;122:1455\u201361.","journal-title":"Chin Med J (Engl)"},{"key":"1091_CR12","doi-asserted-by":"publisher","first-page":"37717","DOI":"10.1038\/srep37717","volume":"6","author":"J Gong","year":"2016","unstructured":"Gong J, Tu W, Han J, He J, Liu J, Han P, et al. Hepatic SATB1 induces paracrine activation of hepatic stellate cells and is upregulated by HBx. Sci Rep. 2016;6:37717.","journal-title":"Sci Rep"},{"key":"1091_CR13","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1002\/hep.22265","volume":"47","author":"S Martin-Vilchez","year":"2008","unstructured":"Martin-Vilchez S, Sanz-Cameno P, Rodriguez-Munoz Y, Majano PL, Molina-Jimenez F, Lopez-Cabrera M, et al. The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells. Hepatology. 2008;47:1872\u201383.","journal-title":"Hepatology"},{"key":"1091_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12916-021-02085-3","volume":"19","author":"X Xie","year":"2021","unstructured":"Xie X, Lv H, Liu C, Su X, Yu Z, Song S, et al. HBeAg mediates inflammatory functions of macrophages by TLR2 contributing to hepatic fibrosis. BMC Med. 2021;19:247.","journal-title":"BMC Med"},{"key":"1091_CR15","first-page":"385","volume":"27","author":"L Wang","year":"2011","unstructured":"Wang L, Chen S, Xu K. IL-17 expression is correlated with hepatitis B-related liver diseases and fibrosis. Int J Mol Med. 2011;27:385\u201392.","journal-title":"Int J Mol Med"},{"key":"1091_CR16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jhep.2019.03.012","volume":"71","author":"RS Wijaya","year":"2019","unstructured":"Wijaya RS, Read SA, Schibeci S, Eslam M, Azardaryany MK, El-Khobar K, et al. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B. J Hepatol. 2019;71:252\u201364.","journal-title":"J Hepatol"},{"key":"1091_CR17","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3892\/ijmm.2012.1148","volume":"30","author":"Q Bai","year":"2012","unstructured":"Bai Q, An J, Wu X, You H, Ma H, Liu T, et al. HBV promotes the proliferation of hepatic stellate cells via the PDGF-B\/PDGFR-beta signaling pathway in vitro. Int J Mol Med. 2012;30:1443\u201350.","journal-title":"Int J Mol Med"},{"key":"1091_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146314","volume":"11","author":"R Sasaki","year":"2016","unstructured":"Sasaki R, Kanda T, Nakamura M, Nakamoto S, Haga Y, Wu S, et al. Possible involvement of hepatitis B virus infection of hepatocytes in the attenuation of apoptosis in hepatic stellate cells. PLoS ONE. 2016;11: e0146314.","journal-title":"PLoS ONE"},{"key":"1091_CR19","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/j.1872-034X.2012.01000.x","volume":"42","author":"X Wu","year":"2012","unstructured":"Wu X, Wang Y, Cui Y, Bai Q, Ze X, Liu T, et al. Hepatitis B virus directly promotes collagen I expression of LX-2 cells without infection in vitro. Hepatol Res. 2012;42:911\u201321.","journal-title":"Hepatol Res"},{"key":"1091_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3892\/br.2013.201","volume":"2","author":"X Liu","year":"2014","unstructured":"Liu X, Tu Y, Deng X, Liang J. The S protein of hepatitis B virus promotes collagen type I expression in hepatic stellate cells by virtue of hepatocytes. Biomed Rep. 2014;2:97\u2013100.","journal-title":"Biomed Rep"},{"issue":"4","key":"1091_CR21","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3892\/mmr.2021.12378","volume":"24","author":"G Yuan","year":"2021","unstructured":"Yuan G, Chen B, Meng Y, Lu J, Shi X, Hu A, et al. Role of the CXCR3-mediated TLRs\/MyD88 signaling pathway in promoting the development of hepatitis B into cirrhosis and liver cancer. Mol Med Rep. 2021;24(4):738.","journal-title":"Mol Med Rep"},{"key":"1091_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.omtn.2020.08.014","volume":"22","author":"H Xie","year":"2020","unstructured":"Xie H, Xie D, Zhang J, Jin W, Li Y, Yao J, et al. ROS\/NF-kappaB signaling pathway-mediated transcriptional activation of TRIM37 promotes HBV-associated hepatic fibrosis. Mol Ther Nucleic Acids. 2020;22:114\u201323.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"1091_CR23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/cbin.11206","volume":"44","author":"J Zhou","year":"2019","unstructured":"Zhou J, Lan Q, Li W, Yang L, You J, Zhang YM, et al. Tripartite motif protein 52 (TRIM52) promoted fibrosis in LX-2 cells through PPM1A-mediated Smad2\/3 pathway. Cell Biol Int. 2019;44(1):108\u201316.","journal-title":"Cell Biol Int"},{"key":"1091_CR24","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/carcin\/bgz109","volume":"41","author":"J Ahodantin","year":"2020","unstructured":"Ahodantin J, Lekbaby B, Bou Nader M, Soussan P, Kremsdorf D. Hepatitis B virus X protein enhances the development of liver fibrosis and the expression of genes associated with epithelial-mesenchymal transitions and tumor progenitor cells. Carcinogenesis. 2020;41:358\u201367.","journal-title":"Carcinogenesis"},{"key":"1091_CR25","first-page":"6832","volume":"11","author":"H Xu","year":"2018","unstructured":"Xu H, Zhou D, Li S. Hepatitis B virus X protein maintains hepatic stellate cell activation by regulating peroxisome proliferator-activated receptor \u03b3. Int J Clin Exp Med. 2018;11:6832\u20139.","journal-title":"Int J Clin Exp Med"},{"key":"1091_CR26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jphs.2020.07.014","volume":"144","author":"CY Kuo","year":"2020","unstructured":"Kuo CY, Chiu V, Hsieh PC, Huang CY, Huang SJ, Tzeng IS, et al. Chrysophanol attenuates hepatitis B virus X protein-induced hepatic stellate cell fibrosis by regulating endoplasmic reticulum stress and ferroptosis. J Pharmacol Sci. 2020;144:172\u201382.","journal-title":"J Pharmacol Sci"},{"key":"1091_CR27","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.bbrc.2013.04.098","volume":"435","author":"Y Zan","year":"2013","unstructured":"Zan Y, Zhang Y, Tien P. Hepatitis B virus e antigen induces activation of rat hepatic stellate cells. Biochem Biophys Res Commun. 2013;435:391\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"1091_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI88881","volume":"127","author":"Y Koyama","year":"2017","unstructured":"Koyama Y, Brenner DA. Liver inflammation and fibrosis. J Clin Invest. 2017;127:55\u201364.","journal-title":"J Clin Invest"},{"key":"1091_CR29","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.3748\/wjg.v20.i10.2515","volume":"20","author":"AJ Czaja","year":"2014","unstructured":"Czaja AJ. Hepatic inflammation and progressive liver fibrosis in chronic liver disease. World J Gastroenterol. 2014;20:2515\u201332.","journal-title":"World J Gastroenterol"},{"key":"1091_CR30","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/cmi.2016.24","volume":"14","author":"Y Yang","year":"2017","unstructured":"Yang Y, Han Q, Hou Z, Zhang C, Tian Z, Zhang J. Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction. Cell Mol Immunol. 2017;14:465\u201375.","journal-title":"Cell Mol Immunol"},{"key":"1091_CR31","doi-asserted-by":"publisher","first-page":"12449","DOI":"10.1074\/jbc.RA120.014317","volume":"295","author":"M Kakizaki","year":"2020","unstructured":"Kakizaki M, Yamamoto Y, Otsuka M, Kitamura K, Ito M, Kawai HD, et al. Extracellular vesicles secreted by HBV-infected cells modulate HBV persistence in hydrodynamic HBV transfection mouse model. J Biol Chem. 2020;295:12449\u201360.","journal-title":"J Biol Chem"},{"key":"1091_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cca.2018.11.009","volume":"488","author":"L Console","year":"2019","unstructured":"Console L, Scalise M, Indiveri C. Exosomes in inflammation and role as biomarkers. Clin Chim Acta. 2019;488:165\u201371.","journal-title":"Clin Chim Acta"},{"key":"1091_CR33","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/resp.13415","volume":"23","author":"AG Stewart","year":"2018","unstructured":"Stewart AG, Thomas B, Koff J. TGF-beta: master regulator of inflammation and fibrosis. Respirology. 2018;23:1096\u20137.","journal-title":"Respirology"},{"key":"1091_CR34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/jmv.23727","volume":"86","author":"M Karimi-Googheri","year":"2014","unstructured":"Karimi-Googheri M, Daneshvar H, Nosratabadi R, Zare-Bidaki M, Hassanshahi G, Ebrahim M, et al. Important roles played by TGF-beta in hepatitis B infection. J Med Virol. 2014;86:102\u20138.","journal-title":"J Med Virol"},{"key":"1091_CR35","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.3748\/wjg.v26.i27.3917","volume":"26","author":"QY Yao","year":"2020","unstructured":"Yao QY, Feng YD, Han P, Yang F, Song GQ. Hepatic microenvironment underlies fibrosis in chronic hepatitis B patients. World J Gastroenterol. 2020;26:3917\u201328.","journal-title":"World J Gastroenterol"},{"key":"1091_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.805625","volume":"8","author":"S Zhong","year":"2021","unstructured":"Zhong S, Zhang T, Tang L, Li Y. Cytokines and chemokines in HBV infection. Front Mol Biosci. 2021;8: 805625.","journal-title":"Front Mol Biosci"},{"key":"1091_CR37","first-page":"59","volume":"8","author":"GH Guo","year":"2009","unstructured":"Guo GH, Tan DM, Zhu PA, Liu F. Hepatitis B virus X protein promotes proliferation and upregulates TGF-beta1 and CTGF in human hepatic stellate cell line, LX-2. Hepatobiliary Pancreat Dis Int. 2009;8:59\u201364.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"1091_CR38","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1172\/JCI118427","volume":"97","author":"Y Do Yoo","year":"1996","unstructured":"Do Yoo Y, Ueda H, Park K, Flanders KC, Lee YI, Jay G, et al. Regulation of transforming growth factor-\u00df1 expression by the hepatitis B virus (HBV) X transactivator. J Clin Investig. 1996;97:388\u201395.","journal-title":"J Clin Investig"},{"key":"1091_CR39","doi-asserted-by":"publisher","first-page":"672","DOI":"10.4049\/jimmunol.2001453","volume":"208","author":"W Li","year":"2022","unstructured":"Li W, Duan X, Zhu C, Liu X, Jeyarajan AJ, Xu M, et al. Hepatitis B and hepatitis C virus infection promote liver fibrogenesis through a TGF-beta1-induced OCT4\/Nanog pathway. J Immunol. 2022;208:672\u201384.","journal-title":"J Immunol"},{"key":"1091_CR40","doi-asserted-by":"publisher","first-page":"43446","DOI":"10.1038\/srep43446","volume":"7","author":"M Wang","year":"2017","unstructured":"Wang M, Gong Q, Zhang J, Chen L, Zhang Z, Lu L, et al. Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis. Sci Rep. 2017;7:43446.","journal-title":"Sci Rep"},{"key":"1091_CR41","doi-asserted-by":"publisher","first-page":"16552","DOI":"10.1038\/srep16552","volume":"5","author":"HY Li","year":"2015","unstructured":"Li HY, Ju D, Zhang DW, Li H, Kong LM, Guo Y, et al. Activation of TGF-beta1-CD147 positive feedback loop in hepatic stellate cells promotes liver fibrosis. Sci Rep. 2015;5:16552.","journal-title":"Sci Rep"},{"key":"1091_CR42","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.3892\/mmr.2015.4221","volume":"12","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Xu M, Qu Y, Li Z, Cai X, Lu L. Analysis of the differential expression of circulating microRNAs during the progression of hepatic fibrosis in patients with chronic hepatitis B virus infection. Mol Med Rep. 2015;12:5647\u201354.","journal-title":"Mol Med Rep"},{"key":"1091_CR43","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1007\/s00204-018-2278-9","volume":"92","author":"L Tao","year":"2018","unstructured":"Tao L, Xue D, Shen D, Ma W, Zhang J, Wang X, et al. MicroRNA-942 mediates hepatic stellate cell activation by regulating BAMBI expression in human liver fibrosis. Arch Toxicol. 2018;92:2935\u201346.","journal-title":"Arch Toxicol"},{"key":"1091_CR44","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s00535-014-0986-3","volume":"50","author":"CF Huang","year":"2015","unstructured":"Huang CF, Sun CC, Zhao F, Zhang YD, Li DJ. miR-33a levels in hepatic and serum after chronic HBV-induced fibrosis. J Gastroenterol. 2015;50:480\u201390.","journal-title":"J Gastroenterol"},{"key":"1091_CR45","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3892\/etm.2020.9600","volume":"21","author":"W Li","year":"2021","unstructured":"Li W, Yu X, Chen X, Wang Z, Yin M, Zhao Z, et al. HBV induces liver fibrosis via the TGF-beta1\/miR-21-5p pathway. Exp Ther Med. 2021;21:169.","journal-title":"Exp Ther Med"},{"key":"1091_CR46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.omtn.2017.11.010","volume":"10","author":"L Zhou","year":"2018","unstructured":"Zhou L, Liu S, Han M, Ma Y, Feng S, Zhao J, et al. miR-185 inhibits fibrogenic activation of hepatic stellate cells and prevents liver fibrosis. Mol Ther Nucleic Acids. 2018;10:91\u2013102.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1091_CR47","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1002\/cbin.11022","volume":"42","author":"X Feili","year":"2018","unstructured":"Feili X, Wu S, Ye W, Tu J, Lou L. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-beta1\/Smad3 pathway in hepatic stellate cells. Cell Biol Int. 2018;42:1370\u20136.","journal-title":"Cell Biol Int"},{"key":"1091_CR48","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/j.1478-3231.2008.01826.x","volume":"28","author":"OA Gressner","year":"2008","unstructured":"Gressner OA, Gressner AM. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases. Liver Int. 2008;28:1065\u201379.","journal-title":"Liver Int"},{"key":"1091_CR49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1089\/vim.2009.0067","volume":"23","author":"W Guo-Qiu","year":"2010","unstructured":"Guo-Qiu W, Nai-Feng L, Xiao-Bo V, Linxian L, Chen Z, Lixia G, et al. The level of connective tissue growth factor in sera of patients with hepatitis B virus strongly correlates with stage of hepatic fibrosis. Viral Immunol. 2010;23:71\u20138.","journal-title":"Viral Immunol"},{"key":"1091_CR50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2217\/fvl-2017-0095","volume":"13","author":"X Pan","year":"2018","unstructured":"Pan X, Zhu F, Li G, Cao H, Liu J. HBx induces expression of CTGF in the transfected hepatoma cell line HepG2. Futur Virol. 2018;13:33\u201342.","journal-title":"Futur Virol"},{"key":"1091_CR51","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.12659\/MSM.895943","volume":"22","author":"X Liu","year":"2016","unstructured":"Liu X, Zhang Y, Wang P, Wang H, Su H, Zhou X, et al. HBX protein-induced downregulation of microRNA-18a is responsible for upregulation of connective tissue growth factor in HBV infection-associated hepatocarcinoma. Med Sci Monit. 2016;22:2492\u2013500.","journal-title":"Med Sci Monit"},{"key":"1091_CR52","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1111\/cas.13014","volume":"107","author":"Z Chen","year":"2016","unstructured":"Chen Z, Tang J, Cai X, Huang Y, Gao Q, Liang L, et al. HBx mutations promote hepatoma cell migration through the Wnt\/beta-catenin signaling pathway. Cancer Sci. 2016;107:1380\u20139.","journal-title":"Cancer Sci"},{"key":"1091_CR53","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/JLB.3MR0121-277R","volume":"110","author":"YA Ni","year":"2021","unstructured":"Ni YA, Chen H, Nie H, Zheng B, Gong Q. HMGB1: an overview of its roles in the pathogenesis of liver disease. J Leukoc Biol. 2021;110:987\u201398.","journal-title":"J Leukoc Biol"},{"key":"1091_CR54","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1002\/hep4.1223","volume":"2","author":"H Gaskell","year":"2018","unstructured":"Gaskell H, Ge X, Nieto N. High-mobility group box-1 and liver disease. Hepatol Commun. 2018;2:1005\u201320.","journal-title":"Hepatol Commun"},{"key":"1091_CR55","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1042\/CS20180177","volume":"132","author":"J Li","year":"2018","unstructured":"Li J, Zeng C, Zheng B, Liu C, Tang M, Jiang Y, et al. HMGB1-induced autophagy facilitates hepatic stellate cells activation: a new pathway in liver fibrosis. Clin Sci (Lond). 2018;132:1645\u201367.","journal-title":"Clin Sci (Lond)"},{"key":"1091_CR56","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1089\/vim.2010.0080","volume":"23","author":"A Albayrak","year":"2010","unstructured":"Albayrak A, Uyanik MH, Cerrah S, Altas S, Dursun H, Demir M, et al. Is HMGB1 a new indirect marker for revealing fibrosis in chronic hepatitis and a new therapeutic target in treatment? Viral Immunol. 2010;23:633\u20138.","journal-title":"Viral Immunol"},{"key":"1091_CR57","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00011-020-01351-z","volume":"69","author":"WH Xie","year":"2020","unstructured":"Xie WH, Ding J, Xie XX, Yang XH, Wu XF, Chen ZX, et al. Hepatitis B virus X protein promotes liver cell pyroptosis under oxidative stress through NLRP3 inflammasome activation. Inflamm Res. 2020;69:683\u201396.","journal-title":"Inflamm Res"},{"key":"1091_CR58","first-page":"4418","volume":"16","author":"D Wu","year":"2018","unstructured":"Wu D, Liang H, Wang H, Duan C, Yazdani H, Zhou J, et al. Hepatitis B virus-X protein regulates high mobility group box 1 to promote the formation of hepatocellular carcinoma. Oncol Lett. 2018;16:4418\u201326.","journal-title":"Oncol Lett"},{"key":"1091_CR59","first-page":"479","volume":"11","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Ren H, Li J, Xue R, Liu H, Zhu Z, et al. Elevated HMGB1 expression induced by hepatitis B virus X protein promotes epithelial-mesenchymal transition and angiogenesis through STAT3\/miR-34a\/NF-kappaB in primary liver cancer. Am J Cancer Res. 2021;11:479\u201394.","journal-title":"Am J Cancer Res"},{"key":"1091_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109737","volume":"123","author":"T He","year":"2020","unstructured":"He T, Zhang N, Wang L, Wan B, Wang X, Zhang L. GPR43 regulates HBV X protein (HBx)-induced inflammatory response in human LO2 hepatocytes. Biomed Pharmacother. 2020;123: 109737.","journal-title":"Biomed Pharmacother"},{"key":"1091_CR61","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.canlet.2017.02.011","volume":"394","author":"S Chen","year":"2017","unstructured":"Chen S, Dong Z, Yang P, Wang X, Jin G, Yu H, et al. Hepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasis. Cancer Lett. 2017;394:22\u201332.","journal-title":"Cancer Lett"},{"key":"1091_CR62","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s11658-021-00305-5","volume":"27","author":"H You","year":"2022","unstructured":"You H, Li Q, Kong D, Liu X, Kong F, Zheng K, et al. The interaction of canonical Wnt\/beta-catenin signaling with protein lysine acetylation. Cell Mol Biol Lett. 2022;27:7.","journal-title":"Cell Mol Biol Lett"},{"key":"1091_CR63","first-page":"960","volume":"9","author":"K Duspara","year":"2021","unstructured":"Duspara K, Bojanic K, Pejic JI, Kuna L, Kolaric TO, Nincevic V, et al. Targeting the Wnt signaling pathway in liver fibrosis for drug options: an update. J Clin Transl Hepatol. 2021;9:960\u201371.","journal-title":"J Clin Transl Hepatol"},{"key":"1091_CR64","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.diff.2019.01.002","volume":"108","author":"L Moparthi","year":"2019","unstructured":"Moparthi L, Koch S. Wnt signaling in intestinal inflammation. Differentiation. 2019;108:24\u201332.","journal-title":"Differentiation"},{"key":"1091_CR65","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40659-019-0217-8","volume":"52","author":"W Li","year":"2019","unstructured":"Li W, Yu X, Zhu C, Wang Z, Zhao Z, Li Y, et al. Notum attenuates HBV-related liver fibrosis through inhibiting Wnt 5a mediated non-canonical pathways. Biol Res. 2019;52:10.","journal-title":"Biol Res"},{"key":"1091_CR66","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1093\/carcin\/bgn111","volume":"29","author":"X Liu","year":"2008","unstructured":"Liu X, Wang L, Zhang S, Lin J, Feitelson MA, Gao H, et al. Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses. Carcinogenesis. 2008;29:1207\u201314.","journal-title":"Carcinogenesis"},{"issue":"6478","key":"1091_CR67","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977.","journal-title":"Science"},{"key":"1091_CR68","doi-asserted-by":"publisher","first-page":"5391","DOI":"10.1021\/pr5008703","volume":"13","author":"X Zhao","year":"2014","unstructured":"Zhao X, Wu Y, Duan J, Ma Y, Shen Z, Wei L, et al. Quantitative proteomic analysis of exosome protein content changes induced by hepatitis B virus in Huh-7 cells using SILAC labeling and LC-MS\/MS. J Proteome Res. 2014;13:5391\u2013402.","journal-title":"J Proteome Res"},{"key":"1091_CR69","doi-asserted-by":"crossref","unstructured":"Zhang Q, Qu Y, Li F, Li B, Li Z, Dong Y, et al. Exosomes derived from hepatitis B virus-infected hepatocytes promote liver fibrosis via miR-222\/TFRC axis. Cell Biol Toxicol. 2022.","DOI":"10.1007\/s10565-021-09684-z"},{"key":"1091_CR70","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.virusres.2017.08.009","volume":"240","author":"NR Kapoor","year":"2017","unstructured":"Kapoor NR, Chadha R, Kumar S, Choedon T, Reddy VS, Kumar V. The HBx gene of hepatitis B virus can influence hepatic microenvironment via exosomes by transferring its mRNA and protein. Virus Res. 2017;240:166\u201374.","journal-title":"Virus Res"},{"key":"1091_CR71","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202002777RR","volume":"35","author":"M Tang","year":"2021","unstructured":"Tang M, Chen Y, Li B, Sugimoto H, Yang S, Yang C, et al. Therapeutic targeting of STAT3 with small interference RNAs and antisense oligonucleotides embedded exosomes in liver fibrosis. FASEB J. 2021;35: e21557.","journal-title":"FASEB J"},{"key":"1091_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.604894","volume":"8","author":"M Wan","year":"2021","unstructured":"Wan M, Han J, Ding L, Hu F, Gao P. Novel immune subsets and related cytokines: emerging players in the progression of liver fibrosis. Front Med (Lausanne). 2021;8: 604894.","journal-title":"Front Med (Lausanne)"},{"key":"1091_CR73","doi-asserted-by":"publisher","first-page":"277","DOI":"10.14218\/JCTH.2015.00026","volume":"3","author":"HJ Li","year":"2015","unstructured":"Li HJ, Zhai NC, Song HX, Yang Y, Cui A, Li TY, et al. The role of immune cells in chronic HBV infection. J Clin Transl Hepatol. 2015;3:277\u201383.","journal-title":"J Clin Transl Hepatol"},{"key":"1091_CR74","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/hep.23983","volume":"53","author":"Z Jin","year":"2011","unstructured":"Jin Z, Sun R, Wei H, Gao X, Chen Y, Tian Z. Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells. Hepatology. 2011;53:219\u201329.","journal-title":"Hepatology"},{"key":"1091_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108650","volume":"223","author":"X Wu","year":"2021","unstructured":"Wu X, Cai B, Lu W, Fu Y, Wei B, Niu Q, et al. HBV upregulated triggering receptor expressed on myeloid cells-1 (TREM-1) expression on monocytes participated in disease progression through NF-Kb pathway. Clin Immunol. 2021;223: 108650.","journal-title":"Clin Immunol"},{"key":"1091_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017484","volume":"6","author":"JY Zhang","year":"2011","unstructured":"Zhang JY, Zou ZS, Huang A, Zhang Z, Fu JL, Xu XS, et al. Hyper-activated pro-inflammatory CD16 monocytes correlate with the severity of liver injury and fibrosis in patients with chronic hepatitis B. PLoS ONE. 2011;6: e17484.","journal-title":"PLoS ONE"},{"key":"1091_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.666370","volume":"12","author":"J Yao","year":"2021","unstructured":"Yao J, Lin C, Jiang J, Zhang X, Li F, Liu T, et al. lncRNA-HEIM facilitated liver fibrosis by up-regulating TGF-beta expression in long-term outcome of chronic hepatitis B. Front Immunol. 2021;12: 666370.","journal-title":"Front Immunol"},{"key":"1091_CR78","doi-asserted-by":"publisher","first-page":"424","DOI":"10.14218\/JCTH.2020.00046","volume":"8","author":"Y Li","year":"2020","unstructured":"Li Y, Li S, Duan X, Yang C, Xu M, Chen L. Macrophage phenotypes and hepatitis B virus infection. J Clin Transl Hepatol. 2020;8:424\u201331.","journal-title":"J Clin Transl Hepatol"},{"key":"1091_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004032","volume":"10","author":"MT Bility","year":"2014","unstructured":"Bility MT, Cheng L, Zhang Z, Luan Y, Li F, Chi L, et al. Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages. PLoS Pathog. 2014;10: e1004032.","journal-title":"PLoS Pathog"},{"key":"1091_CR80","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1111\/liv.14940","volume":"41","author":"D Cheng","year":"2021","unstructured":"Cheng D, Chai J, Wang H, Fu L, Peng S, Ni X. Hepatic macrophages: key players in the development and progression of liver fibrosis. Liver Int. 2021;41:2279\u201394.","journal-title":"Liver Int"},{"key":"1091_CR81","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.dld.2011.11.005","volume":"44","author":"H Li","year":"2012","unstructured":"Li H, Zheng HW, Chen H, Xing ZZ, You H, Cong M, et al. Hepatitis B virus particles preferably induce Kupffer cells to produce TGF-beta1 over pro-inflammatory cytokines. Dig Liver Dis. 2012;44:328\u201333.","journal-title":"Dig Liver Dis"},{"key":"1091_CR82","doi-asserted-by":"publisher","first-page":"G459","DOI":"10.1152\/ajpgi.00338.2021","volume":"322","author":"J Li","year":"2022","unstructured":"Li J, Yu M, Zong R, Fan C, Ren F, Wu W, et al. Deacetylation of Notch1 by SIRT1 contributes to HBsAg- and HBeAg-mediated M2 macrophage polarization. Am J Physiol Gastrointest Liver Physiol. 2022;322:G459\u201371.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1091_CR83","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.immuni.2016.04.008","volume":"44","author":"Y Tian","year":"2016","unstructured":"Tian Y, Kuo CF, Akbari O, Ou JH. Maternal-derived hepatitis B virus e antigen alters macrophage function in offspring to drive viral persistence after vertical transmission. Immunity. 2016;44:1204\u201314.","journal-title":"Immunity"},{"key":"1091_CR84","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41577-021-00549-4","volume":"22","author":"M Iannacone","year":"2022","unstructured":"Iannacone M, Guidotti LG. Immunobiology and pathogenesis of hepatitis B virus infection. Nat Rev Immunol. 2022;22:19\u201332.","journal-title":"Nat Rev Immunol"},{"key":"1091_CR85","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1746-1596-8-40","volume":"8","author":"WJ Du","year":"2013","unstructured":"Du WJ, Zhen JH, Zeng ZQ, Zheng ZM, Xu Y, Qin LY, et al. Expression of interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection. Diagn Pathol. 2013;8:40.","journal-title":"Diagn Pathol"},{"key":"1091_CR86","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.4049\/jimmunol.1203013","volume":"191","author":"Z Tan","year":"2013","unstructured":"Tan Z, Qian X, Jiang R, Liu Q, Wang Y, Chen C, et al. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation. J Immunol. 2013;191:1835\u201344.","journal-title":"J Immunol"},{"key":"1091_CR87","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.4049\/jimmunol.1400861","volume":"193","author":"T Fabre","year":"2014","unstructured":"Fabre T, Kared H, Friedman SL, Shoukry NH. IL-17A enhances the expression of profibrotic genes through upregulation of the TGF-beta receptor on hepatic stellate cells in a JNK-dependent manner. J Immunol. 2014;193:3925\u201333.","journal-title":"J Immunol"},{"key":"1091_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003410","volume":"9","author":"Q Wang","year":"2013","unstructured":"Wang Q, Zhou J, Zhang B, Tian Z, Tang J, Zheng Y, et al. Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23\/IL-17 axis. PLoS Pathog. 2013;9: e1003410.","journal-title":"PLoS Pathog"},{"key":"1091_CR89","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1111\/liv.14438","volume":"40","author":"K Zhang","year":"2020","unstructured":"Zhang K, Liu Y, Yang X, Sun H, Shu X, Zhang Y, et al. HBV promotes the recruitment of IL-17 secreting T cells via chemokines CCL22 and CCL17. Liver Int. 2020;40:1327\u201338.","journal-title":"Liver Int"},{"key":"1091_CR90","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/icb.2010.63","volume":"88","author":"J Li","year":"2010","unstructured":"Li J, Wu W, Peng G, Chen F, Bai M, Zheng M, et al. HBcAg induces interleukin-10 production, inhibiting HBcAg-specific Th17 responses in chronic hepatitis B patients. Immunol Cell Biol. 2010;88:834\u201341.","journal-title":"Immunol Cell Biol"},{"key":"1091_CR91","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/1743-422X-8-270","volume":"8","author":"F Zhang","year":"2011","unstructured":"Zhang F, Yao S, Yuan J, Zhang M, He Q, Yang G, et al. Elevated IL-6 receptor expression on CD4+ T cells contributes to the increased Th17 responses in patients with chronic hepatitis B. Virol J. 2011;8:270.","journal-title":"Virol J"},{"key":"1091_CR92","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/hep.26916","volume":"59","author":"J Zhao","year":"2014","unstructured":"Zhao J, Zhang Z, Luan Y, Zou Z, Sun Y, Li Y, et al. Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment. Hepatology. 2014;59:1331\u201342.","journal-title":"Hepatology"},{"key":"1091_CR93","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/jvh.13352","volume":"27","author":"H Zhang","year":"2020","unstructured":"Zhang H, Yan X, Yang C, Zhan Q, Fu Y, Luo H. Intrahepatic T helper 17 cells recruited by hepatitis B virus X antigen-activated hepatic stellate cells exacerbate the progression of chronic hepatitis B virus infection. J Viral Hepat. 2020;27:1138\u201349.","journal-title":"J Viral Hepat"},{"key":"1091_CR94","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.yexcr.2017.08.001","volume":"359","author":"Y Liu","year":"2017","unstructured":"Liu Y, Li L, Liu J, She WM, Shi JM, Li J, et al. Activated hepatic stellate cells directly induce pathogenic Th17 cells in chronic hepatitis B virus infection. Exp Cell Res. 2017;359:129\u201337.","journal-title":"Exp Cell Res"},{"key":"1091_CR95","doi-asserted-by":"publisher","first-page":"E198","DOI":"10.1111\/hepr.12215","volume":"44","author":"G Feng","year":"2014","unstructured":"Feng G, Zhang JY, Zeng QL, Yu X, Zhang Z, Lv S, et al. Interleukin-21 mediates hepatitis B virus-associated liver cirrhosis by activating hepatic stellate cells. Hepatol Res. 2014;44:E198-205.","journal-title":"Hepatol Res"},{"key":"1091_CR96","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1353","volume":"10","author":"J Li","year":"2021","unstructured":"Li J, Cheng L, Jia H, Liu C, Wang S, Liu Y, et al. IFN-gamma facilitates liver fibrogenesis by CD161(+)CD4(+) T cells through a regenerative IL-23\/IL-17 axis in chronic hepatitis B virus infection. Clin Transl Immunol. 2021;10: e1353.","journal-title":"Clin Transl Immunol"},{"key":"1091_CR97","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s11427-018-9407-2","volume":"61","author":"H Peng","year":"2018","unstructured":"Peng H, Tian Z. NK cells in liver homeostasis and viral hepatitis. Sci China Life Sci. 2018;61:1477\u201385.","journal-title":"Sci China Life Sci"},{"key":"1091_CR98","doi-asserted-by":"publisher","first-page":"44544","DOI":"10.1038\/srep44544","volume":"7","author":"J Shi","year":"2017","unstructured":"Shi J, Zhao J, Zhang X, Cheng Y, Hu J, Li Y, et al. Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-beta-dependent emperipolesis in HBV cirrhotic patients. Sci Rep. 2017;7:44544.","journal-title":"Sci Rep"},{"key":"1091_CR99","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/eci.12669","volume":"46","author":"X Li","year":"2016","unstructured":"Li X, Zhang M, Liu J, Huang Z, Zhao Q, Huang Y, et al. Intrahepatic NK cells function suppressed in advanced liver fibrosis. Eur J Clin Invest. 2016;46:864\u201372.","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"1091_CR100","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3892\/mmr.2022.12724","volume":"25","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wu Y, Shen W, Wang B, Yuan X. Crosstalk between NK cells and hepatic stellate cells in liver fibrosis (Review). Mol Med Rep. 2022;25(6):208.","journal-title":"Mol Med Rep"},{"key":"1091_CR101","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.imlet.2020.12.008","volume":"232","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Qin S, Wei X, Liu X, Guan J, Zhu H, et al. Highly activated TRAIL(+) CD56(bright) NK cells are associated with the liver damage in HBV-LC patients. Immunol Lett. 2021;232:9\u201319.","journal-title":"Immunol Lett"},{"key":"1091_CR102","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/cmi.2015.115","volume":"13","author":"K Bandyopadhyay","year":"2016","unstructured":"Bandyopadhyay K, Marrero I, Kumar V. NKT cell subsets as key participants in liver physiology and pathology. Cell Mol Immunol. 2016;13:337\u201346.","journal-title":"Cell Mol Immunol"},{"key":"1091_CR103","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1053\/j.gastro.2005.10.055","volume":"130","author":"S Radaeva","year":"2006","unstructured":"Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology. 2006;130:435\u201352.","journal-title":"Gastroenterology"},{"key":"1091_CR104","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41577-018-0034-2","volume":"18","author":"CM Crosby","year":"2018","unstructured":"Crosby CM, Kronenberg M. Tissue-specific functions of invariant natural killer T cells. Nat Rev Immunol. 2018;18:559\u201374.","journal-title":"Nat Rev Immunol"},{"key":"1091_CR105","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12775","volume":"90","author":"X Wei","year":"2019","unstructured":"Wei X, Qian J, Yao W, Chen L, Guan H, Chen Y, et al. Hyperactivated peripheral invariant natural killer T cells correlate with the progression of HBV-relative liver cirrhosis. Scand J Immunol. 2019;90: e12775.","journal-title":"Scand J Immunol"},{"key":"1091_CR106","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/hep.27332","volume":"61","author":"E Seki","year":"2015","unstructured":"Seki E, Schwabe RF. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology. 2015;61:1066\u201379.","journal-title":"Hepatology"},{"issue":"1","key":"1091_CR107","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/hep.32239","volume":"76","author":"E Devaraj","year":"2022","unstructured":"Devaraj E, Perumal E, Subramaniyan R, Mustapha N. Liver fibrosis: extracellular vesicles mediated intercellular communication in perisinusoidal space. Hepatology. 2022;76(1):275\u201385.","journal-title":"Hepatology"},{"key":"1091_CR108","doi-asserted-by":"publisher","first-page":"8645","DOI":"10.4238\/2014.October.27.4","volume":"13","author":"HY Chen","year":"2014","unstructured":"Chen HY, Chen ZX, Huang RF, Lin N, Wang XZ. Hepatitis B virus X protein activates human hepatic stellate cells through upregulating TGFbeta1. Genet Mol Res. 2014;13:8645\u201356.","journal-title":"Genet Mol Res"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-023-01091-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-023-01091-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-023-01091-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T11:32:32Z","timestamp":1681731152000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-023-01091-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,11]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1091"],"URL":"https:\/\/doi.org\/10.1186\/s12964-023-01091-7","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.21203\/rs.3.rs-2828038\/v1","asserted-by":"subject"}]},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,11]]},"assertion":[{"value":"14 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors agree for publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that we have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}